ArticleAmerican journal of cancer research2020

A new compound targets the AF-1 of androgen receptor and decreases its activity and protein levels in prostate cancer cells.

Tuyen Thanh Tran et al.PubMed ↗Full text ↗

No numbers read from the abstract.